An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

The hair cycle is composed of four primary phases: anagen, catagen, telogen, and exogen.
Anagen is a highly mitotic phase characterized by the production of a hair shaft from the hair …

Alopecia areata (AA) is a dermatological condition characterized by non-scarring hair loss.
Exact etiopathogenesis of AA is still unknown although it is known that several factors …

Background Nail disorders can arise at any age. About half of all nail disorders are of
infectious origin, 15% are due to inflammatory or metabolic conditions, and 5% are due to …

Background: Alopecia areata is a highly frequent disease with an impact on quality of life
and several treatment options with little clinical confirmatory evidence. Objective: To …

Photobiomodulation (PBM) or low-level laser therapy was discovered over 50 years ago,
when Mester in Hungary observed regrowth of hair in mice when irradiated with a ruby laser …

Background Evidence of TH 1/IFN-γ overactivation as a major pathogenic driver somewhat
conflicts with data supporting robust allergic background in patients with alopecia areata …

Alopecia areata (AA) is an autoimmune disease directed at the hair follicle. Although usually
limited to patchy hair loss over the scalp (focalis), AA can present as total loss of scalp hair …

Alopecia areata is a representative inflammatory skin disease that is associated with various
environmental stimuli. While psychological stress is believed to be a major pathogenetic …

Olumniant (Barcitinib) has gained swift approval by the Food and Drug Administration (FDA)
as a promising medication for the treatment of adults with severe Alopecia Areata. This drug …